• Product NameDynorphin A Proenkephalin B Antibody HRP Conjugated
• Host SpeciesRabbit
• ClonalityPolyclonal
• IsotypeIgG
• PurificationPurified by Protein A.
• ApplicationsWB IHC-P IHC-F ICC
• Species ReactivityHu Ms Rt
• Immunogen DescriptionKLH conjugated synthetic peptide aa 195-245 254 derived from human Proenkephalin-B
• ConjugatesHRP
• Excitation EmissionN A
• Target NameDynorphin A Proenkephalin B
• Alternative Names    ADCA; PENKB; SCA23; Proenkephalin-B; Beta-neoendorphin-dynorphin; Preprodynorphin; PDYN
• Accession No. Swiss-Prot#P01213
  NCBI Gene ID5173
• UniprotP01213
• Gene ID5173;
• Cell Localization Secreted
• Concentration 1mg ml
• Formulation 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
• Storage Shipped at 4˚C. Store at -20˚C for one year. Avoid repeated freeze/thaw cycles.

• WB=1:500-2000 IHC-P=1:50-200 IHC-F=1:50-200 ICC=1:50-200

Leu-enkephalins compete with and mimic the effects of opiate drugs. They play a role in a number of physiologic functions, including pain perception and responses to stress (By similarity). Dynorphin peptides differentially regulate the kappa opioid receptor. Dynorphin A(1-13) has a typical opiod activity, it is 700 times more potent than Leu-enkephalin (By similarity). Leumorphin has a typical opiod activity and may have anti-apoptotic effect.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting